ESC Premium Access

Rate control drugs differ in the prevention of progression of atrial fibrillation

Topic: Antiarrhythmic Drug Treatment

Congress Presentation

About the speaker

Mr Tim Koldenhof

Martini Hospital, Groningen (Netherlands (The))
0 follower

100 more presentations in this session

Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes

Speaker: Professor G. Frommeyer (Munster, DE)

Thumbnail

Inflammation of conduction tissue in patients with arrhythmic phenotype of myocarditis

Speaker: Doctor A. Frustaci (Rome, IT)

Thumbnail

The pleiotropic effect of a deleterious DES mutation in familial atrial fibrillation and the role of PDE4DIP as a genetic modifier for heart block

Speaker: Doctor M. Abou Ziki (New Haven, US)

Thumbnail

Gen-editing to model Short QT syndrome type 5 using human-induced pluripotent stem cell-derived cardiomyocytes

Speaker: Mr L. Maywald (Mannheim, DE)

Thumbnail

Inducibility of atrial fibrillation is associated with disturbed activation pattern in bachmanns bundle

Speaker: Ms L. van Staveren (Rotterdam, NL)

Thumbnail

Access the full session

Arrhythmias, General ePosters

Speakers: Mr T. Koldenhof, Professor G. Frommeyer, Doctor A. Frustaci, Doctor M. Abou Ziki, Mr L. Maywald...
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb